Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Featuring

Kami Maddocks, MD
Hematologist/Oncologist
Medical Director, Infusion Services
Professor, Division of Hematology
The Ohio State University Comprehensive Cancer Center – The James

Program Overview

• Overview of Relapsed/Refractory DLBCL
• Considering Second- and Third-Line Treatment Options
• Update on Clinical Trials
• Question and Answer Session